ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 47 of 1233 for:    "Osteoporosis"

Improved Screening for Osteoporosis (ADOV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02066480
Recruitment Status : Completed
First Posted : February 19, 2014
Last Update Posted : May 19, 2015
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Departemental Vendee

Brief Summary:

Osteoporosis is a disease characterized by skeletal fragility due to decreased bone mass and deterioration of bone microarchitecture , leading to increased fracture risk for low trauma, such as spinal fractures or femoral neck .

It is estimated that 3 million people are living in France , particularly women , with an incidence that increases with age .

This disease is a major public health issue in terms of morbidity and mortality , costs and risk of recurrence (after a first fracture episode) , including risk factors are identified.

However, although bone densitometry is a reliable diagnostic tool and preventive treatments are at our disposal, screening for osteoporosis is still insufficient .

The objective of our study is to improve the detection of osteoporosis in Hospital Departmental Vendee , using a simple questionnaire seeking risk factors followed by bone densitometry or if risk factors are found. Based on the results , the patient will be sent in rheumatology consultation for implementation of treatment if necessary .

Therefore included women hospitalized in medical services , gynecology, surgery and orthopedics Hospital Departmental Vendee , aged 50 to 80 years. Will not be included women who could answer a simple questionnaire and those previously treated for osteoporosis or have already received a bone density there is less than 3 years old .


Condition or disease
Osteoporosis

Study Type : Observational
Actual Enrollment : 3226 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Improved Screening for Osteoporosis in Women Between 50 and 80 Years Hospitalized in Hospital Departmental Vendee
Study Start Date : March 2014
Actual Primary Completion Date : March 2015
Actual Study Completion Date : May 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Osteoporosis

Group/Cohort
women between 50 and 80 years hospitalized in CHD Vendée



Primary Outcome Measures :
  1. Number of patients screened at risk for osteoporosis [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   50 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
women between 50 and 80 years hospitalized CHD Vendée
Criteria

Inclusion Criteria:

  • Women between 50 and 80 years
  • Hospitalized
  • In health services, orthopedics, gynecology, surgery
  • Able to respond to an easy questionnaire
  • Able to give their agreement to participate in the study

Exclusion Criteria:

  • Patients with dementia
  • Patients can not express
  • Patients at end of life
  • Patients previously treated for osteoporosis or recent densitometry (BMD) <3 years
  • Patients could not be seen in time by the nurse during their hospitalization
  • Patients receiving a measure of legal protection

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02066480


Locations
France
Centre hospitalier départemental Vendée
La Roche sur Yon, France, 85925
Sponsors and Collaborators
Centre Hospitalier Departemental Vendee
Investigators
Principal Investigator: Grégoire CORMIER, PH Centre hospitalier départemental Vendée

Responsible Party: Centre Hospitalier Departemental Vendee
ClinicalTrials.gov Identifier: NCT02066480     History of Changes
Other Study ID Numbers: CHD 086-13
First Posted: February 19, 2014    Key Record Dates
Last Update Posted: May 19, 2015
Last Verified: December 2014

Additional relevant MeSH terms:
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases